$ARVN
Arvinas Inc

2022 Q4 Form 10-Q Financial Statement

#000165575922000054 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $45.60M $30.30M $9.285M
YoY Change 73.18% 226.34% 22.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.10M $20.00M $16.01M
YoY Change -19.93% 24.9% 71.62%
% of Gross Profit
Research & Development $98.30M $77.50M $40.60M
YoY Change 58.76% 90.87% 35.3%
% of Gross Profit
Depreciation & Amortization $1.700M $1.600M $1.199M
YoY Change 31.99% 33.49% 39.37%
% of Gross Profit
Operating Expenses $113.4M $97.50M $56.62M
YoY Change 40.39% 72.21% 43.91%
Operating Profit -$67.20M -$47.30M
YoY Change 42.07%
Interest Expense $5.700M $3.200M $360.4K
YoY Change 772.35% 787.85% -53.79%
% of Operating Profit
Other Income/Expense, Net $600.0K $3.200M $219.1K
YoY Change -24.67% 1360.79% 56.47%
Pretax Income -$61.50M -$64.00M -$46.75M
YoY Change 16.04% 36.89% 51.69%
Income Tax $10.80M $2.200M $0.00
% Of Pretax Income
Net Earnings -$82.90M -$66.20M -$46.75M
YoY Change 56.42% 41.6% 51.69%
Net Earnings / Revenue -181.8% -218.48% -503.53%
Basic Earnings Per Share -$1.24 -$0.94
Diluted Earnings Per Share -$1.55 -$1.24 -$938.6K
COMMON SHARES
Basic Shares Outstanding 53.23M shares 53.21M shares 49.80M shares
Diluted Shares Outstanding 53.20M shares 49.80M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.205B $1.271B $1.544B
YoY Change -19.79% -17.73% 521.27%
Cash & Equivalents $81.30M $132.6M $255.7M
Short-Term Investments $1.124B $1.138B $1.289B
Other Short-Term Assets $26.90M $27.20M $23.04M
YoY Change 11.16% 18.07% 558.22%
Inventory
Prepaid Expenses
Receivables $1.000M $1.000M $1.880M
Other Receivables $7.000M $5.800M $6.756M
Total Short-Term Assets $1.240B $1.305B $1.576B
YoY Change -20.12% -17.22% 510.91%
LONG-TERM ASSETS
Property, Plant & Equipment $13.40M $14.00M $11.63M
YoY Change 5.51% 20.4% -0.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $10.80M $11.30M $12.84M
YoY Change -13.6% -11.97%
Total Long-Term Assets $28.60M $30.10M $28.71M
YoY Change -1.72% 4.83% 106.58%
TOTAL ASSETS
Total Short-Term Assets $1.240B $1.305B $1.576B
Total Long-Term Assets $28.60M $30.10M $28.71M
Total Assets $1.269B $1.335B $1.605B
YoY Change -19.78% -16.83% 490.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.700M $7.900M $4.672M
YoY Change -81.79% 69.11% -8.4%
Accrued Expenses $60.50M $1.800M $13.77M
YoY Change 161.9% -86.93% 13.39%
Deferred Revenue $218.6M $193.1M
YoY Change 6.01%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $295.1M $244.6M $182.5M
YoY Change 12.76% 34.02% 362.04%
LONG-TERM LIABILITIES
Long-Term Debt $1.000M $1.000M $1.000M
YoY Change 0.0% 0.0% -50.0%
Other Long-Term Liabilities $407.8M $467.7M $603.6M
YoY Change -24.09% -22.52% 2285.85%
Total Long-Term Liabilities $1.000M $1.000M $604.6M
YoY Change 0.0% -99.83% 2114.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $295.1M $244.6M $182.5M
Total Long-Term Liabilities $1.000M $1.000M $604.6M
Total Liabilities $703.9M $713.3M $787.1M
YoY Change -12.0% -9.38% 1078.34%
SHAREHOLDERS EQUITY
Retained Earnings -$965.4M -$882.5M
YoY Change 41.37%
Common Stock $100.0K $100.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $564.9M $621.5M $817.7M
YoY Change
Total Liabilities & Shareholders Equity $1.269B $1.335B $1.605B
YoY Change -19.78% -16.83% 490.24%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$82.90M -$66.20M -$46.75M
YoY Change 56.42% 41.6% 51.69%
Depreciation, Depletion And Amortization $1.700M $1.600M $1.199M
YoY Change 31.99% 33.49% 39.37%
Cash From Operating Activities -$71.20M -$66.60M $681.5M
YoY Change 99.13% -109.77% -3143.89%
INVESTING ACTIVITIES
Capital Expenditures $1.100M -$2.200M -$1.348M
YoY Change -158.05% 63.2% -3.71%
Acquisitions
YoY Change
Other Investing Activities $20.50M $108.0M -$739.7M
YoY Change -118.02% -114.6% -1318.9%
Cash From Investing Activities $19.40M $105.8M -$741.1M
YoY Change -116.78% -114.28% -1349.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 500.0K 1.200M 266.5M
YoY Change -87.5% -99.55% 773.79%
NET CHANGE
Cash From Operating Activities -71.20M -66.60M 681.5M
Cash From Investing Activities 19.40M 105.8M -741.1M
Cash From Financing Activities 500.0K 1.200M 266.5M
Net Change In Cash -51.30M 40.40M 206.9M
YoY Change -65.19% -80.48% 207.03%
FREE CASH FLOW
Cash From Operating Activities -$71.20M -$66.60M $681.5M
Capital Expenditures $1.100M -$2.200M -$1.348M
Free Cash Flow -$72.30M -$64.40M $682.9M
YoY Change 113.53% -109.43% -3353.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
ARVINAS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001655759
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38672
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2566120
dei Entity Address Address Line1
EntityAddressAddressLine1
5 Science Park
dei Entity Address Address Line2
EntityAddressAddressLine2
395 Winchester Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
New Haven
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06511
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
535-1456
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ARVN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53227521 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132600000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108300000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
5500000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
4500000 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1138100000 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1394300000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000.0 usd
CY2022Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5800000 usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
10700000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21700000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19700000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1304700000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1552500000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14000000.0 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12700000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4800000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3900000 usd
CY2022Q3 arvn Collaboration Contract Asset And Other Assets
CollaborationContractAssetAndOtherAssets
11300000 usd
CY2021Q4 arvn Collaboration Contract Asset And Other Assets
CollaborationContractAssetAndOtherAssets
12500000 usd
CY2022Q3 us-gaap Assets
Assets
1334800000 usd
CY2021Q4 us-gaap Assets
Assets
1581600000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
49700000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54400000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
193100000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
206200000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1800000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1100000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
244600000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
261700000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
464600000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
534300000 usd
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1000000.0 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1000000.0 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3100000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2900000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
713300000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
799900000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53200000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53200000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53000000.0 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4600000 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53000000.0 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-882500000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-682900000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1528700000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1469200000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-24800000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4600000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
621500000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
781700000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1334800000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1581600000 usd
CY2022Q3 us-gaap Revenues
Revenues
30300000 usd
CY2021Q3 us-gaap Revenues
Revenues
9300000 usd
us-gaap Revenues
Revenues
85800000 usd
us-gaap Revenues
Revenues
20400000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
77500000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40600000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216700000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118500000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20000000.0 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16000000.0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64500000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42800000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
97500000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
56600000 usd
us-gaap Operating Expenses
OperatingExpenses
281200000 usd
us-gaap Operating Expenses
OperatingExpenses
161300000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-67200000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-47300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-195400000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-140900000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-400000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1700000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3400000 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
300000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6300000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1200000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3200000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
500000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5900000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2900000 usd
CY2022Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-64000000.0 usd
CY2021Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-46800000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-189500000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-138000000.0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2200000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66200000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-46800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-199600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-138000000.0 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.81
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53200000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53200000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49800000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49100000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66200000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-46800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-199600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-138000000.0 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-2800000 usd
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-100000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-20200000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1200000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-69000000.0 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46900000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-219800000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139200000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
670600000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18800000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66200000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1100000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2800000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
621500000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
582900000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15200000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-46800000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6700000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4600000 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
259900000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-200000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
817700000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
781700000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55400000 usd
us-gaap Net Income Loss
NetIncomeLoss
-199600000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4200000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-20200000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
621500000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
642200000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40100000 usd
us-gaap Net Income Loss
NetIncomeLoss
-138000000.0 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14800000 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4600000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
259900000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1300000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
817700000 usd
us-gaap Profit Loss
ProfitLoss
-199600000 usd
us-gaap Profit Loss
ProfitLoss
-138000000.0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4600000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3500000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-6500000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-5200000 usd
arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
0 usd
arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
1000000.0 usd
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-400000 usd
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1500000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
900000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1300000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
55400000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3500000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
40100000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14000000.0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
900000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-4900000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-700000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2000000.0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12400000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
12900000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5000000.0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7600000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1500000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-900000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-82800000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
718300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-202300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
595100000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
702200000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1402900000 usd
arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
872200000 usd
arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
200500000 usd
arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
59100000 usd
arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
7200000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5700000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2800000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
223400000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1198000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
264500000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4600000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4200000 usd
CY2021Q2 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
160000 sqft
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14800000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4200000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
274700000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25300000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-328200000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112800000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588400000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138100000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
260200000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
300000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8100000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 usd
arvn Accounts Receivable After Allowance For Credit Loss Current Additions
AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions
2400000 usd
CY2021Q2 arvn Base Lease Rent Period
BaseLeaseRentPeriod
P10Y
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior period financial information in order to conform with current period presentation. Accounts payable and Accrued expenses have been condensed into Accounts payable and accrued liabilities, and Interest income and Interest expense have been condensed into Interest income, net
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the use of estimates that affect the reported amount of assets, liabilities, revenue and expenses. These estimates include assumptions and judgments based on historical experience, current conditions, future expectations and other factors the Company considers reasonable. These estimates are reviewed on an ongoing basis and revised as necessary. Actual results could differ from these estimates.
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit Risk and Other Risks and UncertaintiesThe Company is subject to a number of risks similar to other biopharmaceutical companies in the early stage, including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of the Company’s products and protection of proprietary technology. If the Company does not successfully obtain regulatory approval, it will be unable to generate revenue from product sales or achieve profitability.
CY2022Q3 arvn Cash Cash Equivalents Restricted Cash And Marketable Securities
CashCashEquivalentsRestrictedCashAndMarketableSecurities
1300000000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000.0 usd
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1200000 usd
arvn Accounts Receivable After Allowance For Credit Loss Current Additions
AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions
1900000 usd
arvn Accounts Receivable After Allowance For Credit Loss Current Payments Received
AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived
16400000 usd
arvn Accounts Receivable After Allowance For Credit Loss Current Payments Received
AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived
1000000.0 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1900000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12500000 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
arvn Contract With Customer Assets Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements
0 usd
arvn Contract With Customer Assets Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements
12900000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1300000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
11200000 usd
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12800000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
740500000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
45100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-85800000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-20300000 usd
arvn Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements
3000000.0 usd
arvn Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements
738600000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
657700000 usd
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
763400000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.053
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
657700000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
52800000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
190000000.0 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
136500000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
100400000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
63400000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
34100000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
80500000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
657700000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28900000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23400000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14900000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10700000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14000000.0 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12700000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1600000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
500000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
300000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1600000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1000000.0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1500000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
900000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2400000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3200000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.034
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
400000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2100000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2100000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
500000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5100000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
200000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4900000 usd
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10100000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.053
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7900000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31300000 usd
CY2022Q3 arvn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
24800000 usd
CY2021Q4 arvn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
9500000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12200000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12400000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2000000.0 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2800000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1200000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
49700000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54400000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1000000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
200000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
200000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
200000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
200000 usd
CY2022Q3 arvn Long Term Debt Maturity Year Six
LongTermDebtMaturityYearSix
200000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
1000000.0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
39.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7600000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2200000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.034
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66200000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-46800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-199600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-138000000.0 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53200000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53200000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49800000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49100000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.81
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7100000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7100000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5500000 shares

Files In Submission

Name View Source Status
0001655759-22-000054-index-headers.html Edgar Link pending
0001655759-22-000054-index.html Edgar Link pending
0001655759-22-000054.txt Edgar Link pending
0001655759-22-000054-xbrl.zip Edgar Link pending
a101collegearvinasfirstame.htm Edgar Link pending
arvn-20220930.htm Edgar Link pending
arvn-20220930.xsd Edgar Link pending
arvn-20220930x10qex311.htm Edgar Link pending
arvn-20220930x10qex312.htm Edgar Link pending
arvn-20220930x10qex321.htm Edgar Link pending
arvn-20220930x10qex322.htm Edgar Link pending
arvn-20220930_def.xml Edgar Link unprocessable
arvn-20220930_cal.xml Edgar Link unprocessable
arvn-20220930_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
arvn-20220930_lab.xml Edgar Link unprocessable
arvn-20220930_pre.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable